Innate Pharma (IPHA) Shares Outstanding (Entity) (2017 - 2025)

Innate Pharma (IPHA) Shares Outstanding (Entity) (2017 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 254.16 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 147.69 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 200.18 Mn
10 Innate Pharma 157.68 Mn 157.68 Mn - 102.42

Historic Data

Download Data
DateValue
Dec 31, 2025 102.42
Jun 30, 2025 99.00
Dec 31, 2024 92.17
Jun 30, 2024 92.17
Dec 31, 2023 91.04
Jun 30, 2023 91.04
Dec 31, 2022 91.04
Jun 30, 2022 91.04
Dec 31, 2021 91.04
Jun 30, 2021 89.90
Dec 31, 2020 89.90
Jun 30, 2020 89.90
Dec 31, 2019 76.24
Jun 30, 2019 72.83
Dec 31, 2018 67.14
Dec 31, 2017 78.44 Mn